Comparison of Wide-field Retinal Imaging

NCT ID: NCT04255732

Last Updated: 2020-10-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-07

Study Completion Date

2020-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Fundus imaging has become an integral tool in retinal diagnosis. Although single-field fundus photography covers a vital region of the retina, it leaves a large portion of the periphery undiscovered.

Ultra-wide-field imaging systems allowed for visualization of peripheral perfusion abnormalities in myopic eyes that were previously unknown.

In Austria, there are two different wide-field imaging systems available. The first device on the market was the Optos (Optos PLC, Dunfermline, UK) and several years later the Clarus 500 (Carl Zeiss, Meditec AG, Jena, Germany) was introduced.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

While both of the studied imaging systems have the possibility of a 200° view of the retina, we would asses if the differences between the two devices affect the extent of retinal periphery view and if ocular ametropies which come with different retinal pathologies would affect the retinal periphery assessment.

Aim: To compare two CE-marked imaging systems concerning the extent of retinal periphery area viewing.

We would like to perform a prospective observational study that would include patients divided into three groups: myopic patients, hyperopic and emmetropic patients.

Fundus photography will be performed using two ultra-wide-field imaging systems (Optos, Daytona, Optos PLC, Dunfermline, UK and Clarus, 500 Carl Zeiss, Meditec AG, Jena, Germany), performed by the same investigator.

All images with sufficient quality will be exported and saved to hard-disk. The difference in periphery view will be investigated as follows: two retinal photos for each patient will be imported into Photoshop CS6 image-editing system (Adobe, version 13.0.0) where the anatomical landmarks will be matched for each image and the borders will be compared to see if there are differences in retinal periphery area viewing between the two devices.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Extent of retinal periphery area viewing

For the 30 patients fundus photography will be performed using two ultra-wide-field imaging systems.

Group Type OTHER

extent of retinal area viewing Optos, Daytona, Optos PLC, Dunfermline, UK

Intervention Type DEVICE

Comparison of the extent of retinal periphery view between two wide field imaging devices.

extent of retinal area viewing Clarus, 500 Carl Zeiss, Meditec AG, Jena, Germany

Intervention Type DEVICE

Comparison of the extent of retinal periphery view between two wide field imaging devices.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

extent of retinal area viewing Optos, Daytona, Optos PLC, Dunfermline, UK

Comparison of the extent of retinal periphery view between two wide field imaging devices.

Intervention Type DEVICE

extent of retinal area viewing Clarus, 500 Carl Zeiss, Meditec AG, Jena, Germany

Comparison of the extent of retinal periphery view between two wide field imaging devices.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient over 21 years old
* Myopic (at least -5.00Dsph), hyperopic (over +3.00Dsph) and emmetropic patients
* Written informed consent prior to any study specific action.

Exclusion Criteria

* Extensive cataract or severe corneal scaring that would affect image quality
* Fixation problems, nystagmus
* pregnancy- for women in reproductive age a pregnancy test will be performed.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Prim. Prof. Dr. Oliver Findl, MBA

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prim. Prof. Dr. Oliver Findl, MBA

Head of Ophthalmology Department, principal investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Oliver Findl, Prof.

Role: PRINCIPAL_INVESTIGATOR

VIROS, Hanusch Hospital Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna

Vienna, , Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Oliver Findl, Prof.

Role: CONTACT

+43 1 91021-84611

Nino Hirnschall, MD, PhD

Role: CONTACT

+43 1 91021-84611

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Oliver Findl, MD, Prof

Role: primary

+43 1 91021-84611

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UWF

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Wide Field OCTA in Ocular Diseases
NCT07298174 NOT_YET_RECRUITING
Comparing 3 Imaging Systems
NCT05022615 COMPLETED
OCT in Retinal Vein Occlusions
NCT01992575 COMPLETED
Digital Wavefront Sensing
NCT04597255 UNKNOWN NA